Annals of Oncology Advance Access originally published online on May 12, 2005
Annals of Oncology 2005 16(8):1232-1236; doi:10.1093/annonc/mdi242
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
Review |
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?
1 Departement de Pathologie, 2 Service d'Hépato-Gastroentérologie, 3 Service d'Hématologie Clinique, 4 Service d'Immunologie Biologique, Hôpital Henri Mondor, AP-HP, 51 avenue du Maréchal de Lattre de Tassigny, 94 010 Créteil, France
* Correspondence to: Dr C. Copie-Bergman, Département de Pathologie, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94 010 Créteil, France. Tel: +33-1-49-81-2728; Fax: +33-1-49-81-2733; Email: christiane.copie{at}hmn.ap-hop-paris.fr
Background: Helicobacter pylori plays a major role in the pathogenesis of primary gastric MALT lymphoma (GML) and gastric carcinoma. The occurrence of these two diseases metachronously in a same patient is a rare event.
Patients and methods: Gastric biopsies and gastrectomy resection specimens of four patients who developed GML and early gastric cancer (EGC) were analysed by morphology, immunohistochemistry and molecular biology.
Results: Four patients (three males and one female; mean age 48 years) were diagnosed with GML. Helicobacter pylori infection was observed in three cases. Two patients had localized disease (stages IE and IIE, respectively) and were treated with H. pylori eradication therapy followed by an alkylating agent for one patient. Two patients had disseminated disease (stage IV), and were treated with an alkylating agent. Three cases were t(11;18) positive. All patients achieved initially complete lymphoma remission. Long-term endoscopic surveillance detected an EGC at the same location as the lymphoma in all patients at a mean time of 9.5 years (range 2.5–17 years) after lymphoma diagnosis. Gastrectomy specimens showed residual GML in all cases.
Conclusion: Prolonged residual GML could constitute an additional risk factor for the development of gastric carcinoma. Long-term endoscopic surveillance is mandatory in patients treated conservatively for gastric MALT lymphoma.
Key words: gastric cancer, gastric MALT lymphoma, Helicobacter pylori, translocation t(11;18)
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Ono, M. Kato, K. Takagi, J. Kodaira, K. Kubota, Y. Matsuno, Y. Komatsu, and M. Asaka Metachronous gastric cancer following complete remission of gastric MALT lymphoma Ann. Onc., October 1, 2009; 20(10): 1748 - 1749. [Full Text] [PDF]
|
|
|
|
 |
|
 C. M Bacon, M.-Q. Du, and A. Dogan Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists J. Clin. Pathol., April 1, 2007; 60(4): 361 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Cohen, M. Petryk, M. Varma, P. S. Kozuch, E. D. Ames, and M. L. Grossbard Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Oncologist, November 1, 2006; 11(10): 1100 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Raderer, B. Streubel, S. Wohrer, and A. Chott Metachronous gastric MALT lymphoma and early gastric cancer Ann. Onc., April 1, 2006; 17(4): 724 - 724. [Full Text] [PDF]
|
|